Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Deep Dive: Upper Digestive Cancers - Gastric Cancer: From Molecule to Medicine

Aired live on 13 Apr 2022


ESMO Deep Dive: Upper Digestive Cancers - Gastric Cancer: From Molecule to Medicine

Chair: Sarah Derks, Sun Young Rha
Speakers: Patrick Tan, Adam Bass, Filippo Pietrantonio

(Reserved to ESMO Members)

This content is for ESMO members only.


ESMO Members: Take the CME test
and receive 2 ESMO - MORA point

Learning objectives:

  • Understand how new genomic technologies such as single-cell analysis can improve our understanding of gastric cancer intra-tumour heterogeneity, which is emerging as a major barrier to clinical management
  • Understand best practice in the treatment of MSI-H gastric cancer Immunobiology of the disease
  • Understand how features of chromosomal instability lead to different patterns of oncogene activation in gastroesophageal cancers than other GI cancers such as colorectal and pancreatic
  • Understand how intra-tumour heterogeneity can impact response to therapy and resistance
  • Evaluate the need for refined biomarker testing approaches to confront the problems of heterogeneity and the features of chromosomal instability in GE cancers

More recordings from the Deep Dive Webinar series

All latest ESMO Webinar recordings

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.